Market Focus
An American biotechnological company, Moderna Inc. reached an unprecedented deal of $1.5 billion with the Trump administration to supply 100 million does of its experimental vaccine for COVID-19. Under the deal, Moderna Inc. will provide about 100 million does, with the price of around $30.50 per person. In the meantime, the U.S. government also has made agreements with other biotechnological and pharmaceutical companies for potential COVID-19 vaccines, including Johnson and Johnson and Sanofi…etc. With all the potential progress, it essentially elevates the U.S. market.
U.S. stocks and U.S. equities surges in an across the board rally as investors reacts the rebound of gold, the development of vaccines, and Treasury yields retreat to nearly seven- week highs. The S&P 500 gradually approaches the record level prior to when the COVID-19 crashed markets, and the Nasdaq climbs, led by the health care, technology, and utilities sectors.
Market Wrap
Main Pairs Movement
EURUSD has gone into a consolidation phase in the 1.1780 price zone as of writing. The euro seems to be a little stronger than the dollar after the reveal of U.S. consumer price index report surprises on the upside. U.S. consumer price index comes in higher than expected in the month of July, posting 0.6% verse 0.2% expectation. On the euro side, although the Industrial Production data is slightly worse than the expectation, the shared currency capitalized on risk flows and gathered strength against the dollar.
After surging around 30% this year, the precious metal, gold has once fallen below $1900 per ounce level, and continues its bearish momentum for the second- straight day. The huge pullback suggests that a price movement is driven more by short- term trading than a fundamental shift in sentiment. Another main factor to drag gold down is the boosted by global stimulus plans to support countries’ economies. As the global economy is suffering from catastrophes caused by the pandemic, countries are doing their best to save and revive economies.
COVID-19 Data (EOD):
Technical Analysis:
GBPUSD(H4)
GBPUSD extends its decline as of writing. In the 4- hour chart, it shows that a mere bearish mode has contained intraday attempts to advance; at the same time, the pair is currently trading below the 20 SMA. The pair is currently testing its first support level at 1.3029; the bearish momentum will likely accelerate toward 1.2973 level after breaking through its support level. Additionally, MACD indicator advises a selling trend on the doward reversal.
Resistance: 1.3068, 1.3155
Support: 1.3029, 1.2973
USDCHF (H4)
USDCHF remains neutral as consolidation is extending. With its resistance level at 0.9192 intact, several failures to challenge the resistance suggest that a further fall is still expected. However, the pair is expected to remain in a consolidation zone for a while since it is trading on the 20 SMA; in the meanwhile, the RSI indicator at the 45.58 mark shows that the pair is neither overbought nor oversold. Though, if the pair eventually breaks through 0.9107, it will likely confirm short term bottoming toward 0.9065.
Resistance: 0.9192, 0.9220
Support: 0.9107, 0.9065
CADJPY(H4)
CADJPY extends its bullish momentum as of writing. The pair is testing a new 2- month high, 87.90, back in June 2020. In the short- run, the RSI indicator suggests the condition of overbought, reflecting a positive momentum. In the 4- hour chart, trading firmly above the 20 SMA suggests a bullish mode for CADJPY. That being said, CADJPY is looking for an upside recovery, shifting to bullish in the short run.
Resistance: 80.697, 80.937
Support: 80.004, 79.632, 79.114
Economic Data
Pendidikan
Perusahaan
Pertanyaan Umum
Promosi
Peringatan Resiko: Perdagangan CFD memiliki tingkat risiko yang tinggi dan mungkin tidak cocok untuk semua investor. Leverage dalam perdagangan CFD dapat memperbesar keuntungan dan kerugian, berpotensi melebihi modal awal Anda. Sangat penting untuk sepenuhnya memahami dan mengakui risiko terkait sebelum melakukan perdagangan CFD. Pertimbangkan situasi keuangan Anda, tujuan investasi, dan toleransi risiko sebelum membuat keputusan perdagangan. Kinerja masa lalu tidak menunjukkan hasil di masa depan. Lihat dokumen hukum kami untuk pemahaman komprehensif tentang risiko perdagangan CFD.
Informasi di situs web ini bersifat umum dan tidak memperhitungkan tujuan pribadi, situasi keuangan, atau kebutuhan Anda. VT Markets tidak bertanggung jawab atas relevansi, keakuratan, ketepatan waktu, atau kelengkapan informasi situs web apa pun.
Layanan dan informasi kami di situs web ini tidak diberikan kepada penduduk negara tertentu, termasuk Amerika Serikat, Singapura, Rusia, dan yurisdiksi yang tercantum dalam FATF dan daftar sanksi global. Produk-produk tersebut tidak dimaksudkan untuk didistribusikan atau digunakan di lokasi mana pun yang mana distribusi atau penggunaan tersebut akan melanggar hukum atau peraturan setempat.
VT Markets adalah nama merek dengan banyak entitas resmi dan terdaftar di berbagai yurisdiksi.
· VT Markets (Pty) Ltd adalah Penyedia Layanan Keuangan (FSP) resmi yang terdaftar dan diatur oleh Financial Sector Conduct Authority (FSCA) Afrika Selatan dengan nomor lisensi 50865.
· VT Markets Limited adalah dealer investasi yang disahkan dan diatur oleh Komisi Jasa Keuangan Mauritius (FSC) dengan nomor lisensi GB23202269.
VT Markets Ltd, terdaftar di Republik Siprus dengan nomor registrasi HE436466 dan alamat terdaftar di Archbishop Makarios III, 160, Lantai 1, 3026, Limassol, Siprus, hanya bertindak sebagai agen pembayaran untuk VT Markets. Entitas ini tidak berwenang atau berlisensi di Siprus dan tidak melakukan aktivitas apa pun yang diatur.
Hak Cipta © 2025 VT Markets.